CVRI Recognizes Newly Selected Distinguished Investigator, Michael J. Toth, PhD
The CVRI seeks to highlight excellence in research and to foster the next generation of cardiovascular researchers. As such, the CVRI Board of Directors has recently selected Michael J. Toth, PhD for designation as CVRI Distinguished Investigator.
Dr. Toth, nominated by Dr. Philip Ades, has established extraordinary success as a UVM researcher in the field of muscle physiology. His studies over the years have related to the role of skeletal muscle dysfunction as is seen with aging, chronic heart failure, disuse, and the presence of chronic disease such as arthritis and cancer. His studies utilize ingenious techniques developed by himself and his colleagues that include mounting single muscle fibers for detailed functional testing. Dr. Toth has also published a total of 106 peer reviewed publications, many in the strongest journals including J Appl Physiol, Am J Physiol, Circlulation, JACC and Metabolism.
CVRI-VT recognizes investigators who are performing sustained, impactful cardiovascular research by naming them as "Distinguished Investigators." Candidates for this award are nominated by members of the Board of Directors and previous Distinguished investigators. Those accepted for the award will hold the designation, are expected to participate in key CVRI-VT activities, and are recognized by CVRI-VT with a reception and a commitment for funding.
Dr. Toth joins the following group of prestigious Distinguished Investigators: Philip Ades, MD, Joseph Brayden, PhD, Martin LeWinter, MD, George Osol, PhD, Russell Tracy, PhD, and Kathleen Trybus, PhD.